… This study sought to provide post–cardiac transplant survival … mechanical circulatory support
and cardiac transplantation. … outcomes of patients with ACM who receive heart transplant …

… programs, driven by the anchoring bias of recent anecdotal experience and outcomes. …
characteristics and outcomes of patients who receive transplants for adriamycin-associated …

… cardiomyopathy (CCMP… outcomes after heart transplant in those with and without a history
of cancer. Conversely, data regarding heart transplant in CCMP have shown mixed outcomes …

… -induced cardiomyopathy (CCMP) and advanced HF are often precluded from heart
transplantation because of … Short-term and long-term survival rates were similar to those with other …

… cardiac insufficiency and eventually congestive heart failure (CHF), resulting in the need for
a heart transplant … While the heart rate of the mice was keeping at 450–500 bpm, the images …

… of heart transplantation in adults due to chemotherapy-induced cardiotoxicity in a transplant
… serious complications of cancer treatment, with high morbidity and mortality rates. Chronic …

… favorable survival outcomes when compared to other cardiomyopathy cohorts. A study of
the UNOS database with 7169 heart transplant recipients identified 1.5% (n = 107) of those …

… , in carefully selected cancer survivors, clinical outcome after implantation of a left ventricular
assist device and heart transplantation are comparable with other causes of heart failure. …

… In patients with chemotherapy-related cardiomyopathy, other … : Outcome for heart
transplantation in patients with PTM is acceptable in terms of survival, and occurrence post-transplant …

Background: High doses of doxorubicin put cancer patients at risk for developing dilated
cardiomyopathy. Previously, we showed that doxorubicin treatment decreases SIRT3 (sirtuin 3), …